Search - tctmd.com

Displaying 81 - 100 of 2133

Sort: Relevancy | Date

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

News Daily News

Simple Sitting-Rising Test Linked to Natural and CV Mortality

L.A. McKeown

June 18, 2025

News Daily News

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

Caitlin E. Cox

June 17, 2025

News Daily News

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

L.A. McKeown

June 17, 2025

News Daily News

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Michael O'Riordan

June 13, 2025

News Daily News

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

Michael O'Riordan

June 10, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Daily News

EMS Practices for OHCA Diverge Between Black/Hispanic, White Areas

Caitlin E. Cox

June 05, 2025

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Conference News ESOC 2025

Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors

Todd Neale

June 02, 2025

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

News Conference News ESC Heart Failure 2025

AI-ECG Helps Find Subclinical Heart Failure in Kenya

Todd Neale

May 19, 2025

News Daily News

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

Caitlin E. Cox

May 19, 2025

News Conference News European Congress on Obesity 2025

Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity

Michael O'Riordan

May 16, 2025

News Daily News

CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women

L.A. McKeown

May 14, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Conference News SCAI 2025

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

L.A. McKeown

May 09, 2025

News Daily News

Conversion Therapy Tied to Worse CV Risk Factors in Sexual, Gender Minorities

Caitlin E. Cox

May 08, 2025

Advertisement

Amylin Analogue Boosts Weight Loss When Added to GLP-1

Simple Sitting-Rising Test Linked to Natural and CV Mortality

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

Majority of US Adults Have High Long-term Risk of CVD: NHANES

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

EMS Practices for OHCA Diverge Between Black/Hispanic, White Areas

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

AI-ECG Helps Find Subclinical Heart Failure in Kenya

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity

CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

Conversion Therapy Tied to Worse CV Risk Factors in Sexual, Gender Minorities

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content